- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03445130
A Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients
February 2, 2022 updated by: NYU Langone Health
A Randomized Prospective Placebo-Controlled Study of the Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Surgery Patients
The purpose of this study is to determine the effects of lavender aromatherapy on preoperative anxiety by measuring changes in pulse rate and anxiety core using Spielberger State-Trait Anxiety Index questionnaires and on postoperative pain medicine usage.
Study participants will then be randomized into one of four groups; either they will receive 2 drops of lavender (Lavandula Angustifolia) oil (LO) or 2 drops of Michelia Alba Leaf oil (MA) or 2 drops of unscented Almond oil (AO) or two drops water on the inside of an oxygen face mask for 15 minutes.
Linalool makes up ~30% of Lavandula Angustifolia oil and is believed to be its most active anti-anxiety component.
Before and after treatment, anxiety level will be measured using the Spielberger State-Trait Anxiety Inventory.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women, older than 18, American Society of Anesthesiologists (ASA) classification I-III, undergoing elective breast surgery on Tisch 10th floor Day Surgery. Cancer patients are included.
Exclusion Criteria:
- History of asthma, bronchitis, COPD, contact dermatitis to cosmetic fragrances, positive patch test, pregnancy, and significant laboratory abnormalities.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Lavandula Angustifolia oil (LO)
2 Drops in Oxygen Mask
|
two drops on the inside of an oxygen face mask for 15 minutes.
|
|
Active Comparator: Michelia Alba Leaf oil (MA)
2 Drops in Oxygen Mask
|
two drops on the inside of an oxygen face mask for 15 minutes.
|
|
Active Comparator: Almond oil (AO)
2 Drops in Oxygen Mask
|
two drops on the inside of an oxygen face mask for 15 minutes.
|
|
Active Comparator: Water
2 Drops in Oxygen Mask
|
two drops on the inside of an oxygen face mask for 15 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in anxiety as measured by the change in baseline STAI scores
Time Frame: 20 Minutes
|
Spielberger State-Trait Anxiety Inventory (STAI) is a self-reported instrument.
It was designed to assess levels of state anxiety and traint anxiety, through 40 items scored by a likert-scale.
State anxiety can be defined as a transient momentary emotional status that results from situational stress.
|
20 Minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Wajda, MD, New York Langone Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2019
Primary Completion (Actual)
September 23, 2020
Study Completion (Actual)
September 23, 2020
Study Registration Dates
First Submitted
February 20, 2018
First Submitted That Met QC Criteria
February 23, 2018
First Posted (Actual)
February 26, 2018
Study Record Updates
Last Update Posted (Actual)
February 18, 2022
Last Update Submitted That Met QC Criteria
February 2, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-01844
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All of the individual participant data collected during the trial, after deidentification.
Researchers who provide a methodologically sound proposal.
IPD Sharing Time Frame
Beginning 9 months and ending 36 months following article publication.
IPD Sharing Access Criteria
Requests should be directed to Lola.Franco@nyulangone.org.
To gain access, data requestors will need to sign a data access agreement.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
University of CalabriaNot yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking AnxietyItaly
-
Clinica Alemana de SantiagoUniversidad del DesarrolloRecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After SurgeryChile
-
Boston Medical CenterPatient-Centered Outcomes Research Institute; Boston University; Johns Hopkins... and other collaboratorsCompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety DisordersUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Abant Izzet Baysal UniversityRecruitingAnxiety | Parental AnxietyTurkey (Türkiye)
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiActive, not recruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Institut National de la Santé Et de la Recherche...Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and FearFrance
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
Clinical Trials on Lavandula Angustifolia oil (LO)
-
Scott Hollenbeck, MDdōTERRA InternationalCompletedPain, PostoperativeUnited States
-
University of Sao PauloEnrolling by invitation
-
Qassim UniversityCompleted
-
University of Southern CaliforniaCompleted
-
University of Sao PauloCompletedAcute Pain | Nurse's Role | Perioperative/Postoperative Complications | CAMBrazil
-
Goknur Demir HacimusalarCompletedHemodialysis PatientsTurkey (Türkiye)
-
TC Erciyes UniversityCompletedQuality of Life | Pain | Hemodialysis | Aromatherapy | Muscle CrampsTurkey
-
Wake Forest University Health SciencesCompleted
-
Mayo ClinicCompleted
-
Oregon Health and Science UniversityCompleted